---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-23-000102"
form_type: "8-K"
ticker: "STEX"
cik: "0001530766"
company_name: "Streamex Corp."
filed_at: "2023-02-08T23:59:59+00:00"
generated_at: "2026-06-19T21:43:18.916774+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# BioSig raises $1.37M via PIPE of common stock and warrants

## Summary
- Entered Securities Purchase Agreement on Feb 3, 2023 for sale of 1,591,750 shares at $0.8588/share and warrants for 795,875 shares at $0.7963, total proceeds $1.37M.
- Warrants exercisable six months after issuance, expire 5.5 years from issuance.
- Laidlaw & Company received placement agent warrants for 87,331 shares (Feb PIPE) and 71,214 shares (Jan PIPE).
- Securities issued in reliance on Section 4(a)(2) and Regulation D exemption.

## SEC filing metadata
- accession: 0001185185-23-000102
- form_type: 8-K
- ticker: STEX
- cik: 0001530766
- company_name: Streamex Corp.
- filed_at: 2023-02-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1530766/000118518523000102/0001185185-23-000102-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1530766/000118518523000102/biosig20230207b_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-23-000102
- JSON: https://secwatch.observer/filing/0001185185-23-000102.json
- Plain text: https://secwatch.observer/filing/0001185185-23-000102.txt

## Key facts
- Material Agreements
  Streamex Corp. entered into Securities Purchase Agreement with certain institutional and accredited investors valued at $1,366,994.90 (effective 2023-02-03).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain institutional and accredited investors
  - Value: $1,366,994.90
  - Effective: 2023-02-03
  source text: On February 3, 2023, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional and accredited investors (the “Investors”), pursuant to which the Company sold to the Investors an aggregate of 1,591,750 shares (the “Shares”) of the Company’s common stock
  evidence_url: https://www.sec.gov/Archives/edgar/data/1530766/000118518523000102/0001185185-23-000102-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.